Cargando…
Routinely collected data for randomized trials: promises, barriers, and implications
BACKGROUND: Routinely collected health data (RCD) are increasingly used for randomized controlled trials (RCTs). This can provide three major benefits: increasing value through better feasibility (reducing costs, time, and resources), expanding the research agenda (performing trials for research que...
Autores principales: | Mc Cord, Kimberly A., Al-Shahi Salman, Rustam, Treweek, Shaun, Gardner, Heidi, Strech, Daniel, Whiteley, William, Ioannidis, John P. A., Hemkens, Lars G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765645/ https://www.ncbi.nlm.nih.gov/pubmed/29325575 http://dx.doi.org/10.1186/s13063-017-2394-5 |
Ejemplares similares
-
Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study
por: Mc Cord, Kimberly A, et al.
Publicado: (2021) -
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
por: Hemkens, Lars G, et al.
Publicado: (2016) -
The reporting of studies using routinely collected health data was often insufficient
por: Hemkens, Lars G., et al.
Publicado: (2016) -
Reporting transparency and completeness in trials: Paper 4 - reporting of randomised controlled trials conducted using routinely collected electronic records – room for improvement
por: McCall, Stephen J., et al.
Publicado: (2022) -
A good use of time? Providing evidence for how effort is invested in primary and secondary outcome data collection in trials
por: Gardner, Heidi, et al.
Publicado: (2022)